ArticleFrontiers in public health2026
Burden and predictors of advanced HIV disease among people living with HIV at Zewditu Memorial Hospital in Addis Ababa, Ethiopia.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Globally, about 630,000 (500,000-820,000) deaths occur annually among people living with HIV (PLHIV). Advanced HIV disease (AHD) continues to be an important contributor to HIV-related mortality in sub-Saharan Africa. Despite a significant positive association with mortality, the prevalence and factors that lead to AHD in Addis Ababa have not been studied well. Thus, this study aimed at investigating the prevalence and contributing factors of AHD in Addis Ababa, Ethiopia. Methods: We conducted a facility-based cross-sectional study among PLHIV attending Zewditu Memorial Hospital in Addis Ababa, Ethiopia. Data were collected through an interviewer-administered questionnaire and abstraction of 414 sturdy participants' medical records using Open Data Kit. In the current study, AHD was defined using the objective criterion of a CD4 count < 200 cells/μL. Analysis was done using SPSS version 28 for descriptive and analytic statistics, and statistical significance was set at Results: The overall prevalence of AHD, as well as among ART-naive and ART-experienced individuals, was 29.7% (95% CI: 25.4-34.4%), 51.4% (95% CI: 34.4-68.1%), and 27.6% (95% CI: 23.1-32.4%), respectively. Very severe and severe AHD accounts for 21.9% (95% CI: 15.0-30.3%) and 17.9% (95% CI: 11.5-25.8%) of the study participants, respectively. Further analysis of the determinants revealed that AHD was more likely to manifest in men (AOR of 2.41, 95% CI: 1.23-4.74); manual and service workers such as daily laborers, drivers, cleaners, and security guards (AOR of 2.75, 95% CI: 1.18-6.40); those with lower average monthly incomes of 5,001-10,000 birr (AOR of 3.27, 95% CI: 1.11-9.64) and less than 5,000 birr (AOR of 4.14, 95% CI: 1.49-11.54); the malnourished individuals (AOR of 5.82, 95% CI: 1.97-17.18); and those non-adherent to ART (AOR of 9.88, 95% CI: 4.32-22.03). Conclusion: The burden of AHD remains substantial, disproportionately affecting ART-naïve individuals. Male sex, low monthly income, being a manual and service worker, malnutrition, and ART non-adherence were key factors associated with HIV progression. Implementing the WHO-recommended AHD package may help reduce AHD and improve clinical outcome and ultimately death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.